Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Trading Arrangement: Trading Arrangement [Axis] Pre-funded warrants issued and outstanding Pre Funded Warrants [Member] Pre Funded Warrants Maximum Maximum [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Title of 12(b) Security Title of 12(b) Security Subsequent Event Subsequent Event [Member] Document Fiscal Year Focus Document Fiscal Year Focus Amount allocated to performance obligation Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized Adjustment to Compensation, Amount Adjustment to Compensation Amount Customer [Axis] Customer [Axis] Schedule of Fair Value Measurements On a Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Common stock, $0.0001 par value; 120,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 14,708,910 shares issued and outstanding as of June 30, 2026 and 14,577,609 shares issued and outstanding as of December 31, 2025. Common Stock, Value, Issued 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Compensation-related Employee-related Liabilities, Current Schedule of Long-Term Debt Schedule of Long-Term Debt Instruments [Table Text Block] Line of Credit Line of Credit [Member] Entity Ex Transition Period Entity Ex Transition Period Restatement Determination Date Restatement Determination Date Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Warrants to purchase of shares (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Schedule of Prepaid Expense and Other Current Assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Amendment Flag Amendment Flag Current liabilities: Liabilities, Current [Abstract] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Oxford Term Loans Oxford Term Loans [Member] Oxford Term Loans Payment of fees associated with debt Payments of Debt Issuance Costs, Secured Debt Payments of Debt Issuance Costs, Secured Debt Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Entity Address, State or Province Entity Address, State or Province Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Clinical trials Accrued Clinical Trials, Current Accrued Clinical Trials, Current PEO Total Compensation Amount PEO Total Compensation Amount Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Cliff Vesting Share-Based Payment Arrangement, Tranche One [Member] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Number of reportable segments Number of Reportable Segments Total current liabilities Liabilities, Current Entity Address, City or Town Entity Address, City or Town Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Statement of Financial Position [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Equipment, depreciation, and facility Research And Development Expense, Equipment, Depreciation, And Facility Research And Development Expense, Equipment, Depreciation, And Facility Level 2 Fair Value, Inputs, Level 2 [Member] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Aggregate principal amount Line of Credit Facility, Maximum Borrowing Capacity Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Professional fees Professional Fees, Current Professional Fees, Current License fee revenue License [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Payable for purchase of fixed assets Capital Expenditures Incurred but Not yet Paid Schedule of Segment Reporting Segment Reporting [Table Text Block] Loss on disposal of fixed assets Gain (Loss) on Disposition of Property Plant Equipment Use of Estimates Use of Estimates, Policy [Policy Text Block] Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Accrued Research and Development and Clinical Trial Costs Research and Development Expense, Policy [Policy Text Block] Total debt Total debt Long-Term Debt Warrant price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Schedule of Operating Lease Maturity Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Supplemental schedule of non-cash investing and financing activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Document Period End Date Document Period End Date Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two STOCKHOLDERS’ EQUITY (DEFICIT) Equity [Text Block] Security Exchange Name Security Exchange Name Interest rate, effective percentage Debt Instrument, Interest Rate, Effective Percentage Nonrefundable, payment Collaborative Arrangement, Nonrefundable Payment Collaborative Arrangement, Nonrefundable Payment Clinical trials Clinical Trails, Prepaid Expense Current Clinical Trails, Prepaid Expense Current Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Entity Shell Company Entity Shell Company Number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Current portion of operating lease liability Less: current portion of operating lease liability Operating Lease, Liability, Current Segment Information Segment Reporting, Policy [Policy Text Block] Schedule of Property and Equipment, Net Property, Plant, and Equipment [Table Text Block] Name Outstanding Recovery, Individual Name Net loss per share, basic and diluted Earnings Per Share [Abstract] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] General and administrative expense General and Administrative Expense [Abstract] Total liabilities Liabilities Trading Symbol Trading Symbol Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Shares used in computing net loss per share, basic and diluted Weighted Average Number of Shares Outstanding, Basic [Abstract] Company Selected Measure Name Company Selected Measure Name Sale of Stock [Domain] Sale of Stock [Domain] Accretion of debt discount and non-cash interest expense Amortization of Debt Issuance Costs and Discounts 2030 Long-Term Debt, Maturity, After Year Three Long-Term Debt, Maturity, After Year Three Term loan Total future minimum payments Long-Term Debt, Gross Credit Facility [Domain] Credit Facility [Domain] Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Other receivables Other Receivables, Net, Current Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Warrants to purchase common stock Warrants issued and outstanding Warrant [Member] Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Other non-current assets Increase (Decrease) in Other Noncurrent Assets Other general and administrative Other General and Administrative Expense Award Timing Predetermined Award Timing Predetermined [Flag] Clinical trials Research And Development Expense, Clinical Trials Research And Development Expense, Clinical Trials Aggregate intrinsic value of stock options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Level 1 Fair Value, Inputs, Level 1 [Member] Computer software Software, Internally Developed [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Line of credit facility, maximum borrowing capacity, additional funds Line Of Credit Facility, Maximum Borrowing Capacity, Additional Funds Line Of Credit Facility, Maximum Borrowing Capacity, Additional Funds All Executive Categories All Executive Categories [Member] Operating lease liability Increase (Decrease) in Operating Lease Liability Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Vesting [Domain] Vesting [Domain] Plan Name [Domain] Plan Name [Domain] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Outstanding, beginning balance (in dollars per share) Outstanding, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Schedule of Common Stock Reserved for Future Issuance Schedule of Common Stock Reserved For Future Issuance [Table Text Block] Schedule of Common Stock Reserved For Future Issuance Operating right-of-use asset Operating Lease, Right-of-Use Asset Software licenses Software License, Prepaid Current Software License, Prepaid Current Debt Disclosure [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Line of credit facility, maximum borrowing capacity, funded upon execution of the amendment Line Of Credit Facility, Maximum Borrowing Capacity, Funded Upon Execution Of The Amendment Line Of Credit Facility, Maximum Borrowing Capacity, Funded Upon Execution Of The Amendment Minimum Minimum [Member] Expiration Date Trading Arrangement Expiration Date Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Income Statement Location [Axis] Location, Statement of Income, Balance [Axis] Non-cash lease expense Noncash Operating Lease Expense Noncash Operating Lease Expense Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Total assets measured at fair value Cash and Cash Equivalents, Fair Value Disclosure Weighted Average Remaining Contractual Term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Other income (expense): Other Income and Expenses [Abstract] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Aggregate Intrinsic Value, vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Exercise Price Award Exercise Price Cash flows from investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Remaining term of operating lease (in years) Lessee, Operating Lease, Remaining Lease Term Segment Reporting [Line Items] Segment Reporting [Line Items] Unrecognized stock-based compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segments [Domain] Segments [Domain] DEBT Debt Disclosure [Text Block] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Other receivables Increase (Decrease) in Other Receivables Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Secured Debt Secured Debt [Member] Fair value of warrants issued to lender in conjunction with Amended 2025 Loan Agreement (as defined in Note 3) Other Noncash Investing And Financing Items, Warrant Liabilities Incurred Other Noncash Investing And Financing Items, Warrant Liabilities Incurred Adoption Date Trading Arrangement Adoption Date Annual interest rate Debt Instrument, Interest Rate, Stated Percentage Total stockholders’ equity (deficit) Beginning balance Ending balance Equity, Attributable to Parent Total other expense Other expense Nonoperating Income (Expense) Assets Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Total operating lease liability Operating Lease, Liability Insider Trading Policies and Procedures [Line Items] Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Prepaid expenses and other current assets Prepaid expense and other current assets Prepaid Expense and Other Assets, Current Private Placement Private Placement [Member] OTHER FINANCIAL INFORMATION Supplemental Balance Sheet Disclosures [Text Block] Term A Term Loan A [Member] Term Loan A COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Antidilutive securities excluded from earnings per share computation (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Number of operating segments Number of Operating Segments Schedule of Potential Dilutive Securities Excluded from Diluted Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Entity Central Index Key Entity Central Index Key Less: accumulated depreciation and amortization Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization All Adjustments to Compensation All Adjustments to Compensation [Member] Stockholders’ equity (deficit) Equity [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Income Taxes Income Tax, Policy [Policy Text Block] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Income Statement [Abstract] Document Transition Report Document Transition Report Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Operating expenses: Operating Expenses [Abstract] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Schedule of Weighted-Average Assumptions Used to Estimate Fair Value Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Total fair value of stock options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate City Area Code City Area Code 2024 Plan 2024 Plan [Member] 2024 Plan All Individuals All Individuals [Member] SUBSEQUENT EVENTS Subsequent Events [Text Block] Name Forgone Recovery, Individual Name Research and development expense Research and Development [Abstract] Weighted-average period of recognition (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Term B Term Loan B [Member] Term Loan B Statement [Line Items] Statement [Line Items] Total assets Assets Revenue, number of performance obligation Revenue from Contract with Customer, Excluding Assessed Tax, Number Of Performance Obligation Revenue from Contract with Customer, Excluding Assessed Tax, Number Of Performance Obligation Warrants, Pre-Funded Warrants, Pre-Funded [Member] Warrants, Pre-Funded Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Total common stock reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Weighted average fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Interest expense Interest Expense, Nonoperating Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] EQUITY COMPENSATION PLAN Share-Based Payment Arrangement [Text Block] PEO PEO [Member] 2028 (10 months) Long-Term Debt, Maturity, Year Two Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Clinical drug substance and product manufacturing Clinical Drug Substance and Product Manufacturing, Prepaid Expense Current Clinical Drug Substance and Product Manufacturing, Prepaid Expense Current Total stock-based compensation expense Share-Based Payment Arrangement, Expense Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Issuance of shares upon exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Subsequent Event Type [Domain] Subsequent Event Type [Domain] Periodic payment terms, final payment amount Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid Accumulated Deficit Retained Earnings [Member] Non-current portion of operating lease liability Non-current portion of operating lease liability Operating Lease, Liability, Noncurrent Scithera, Inc. Scithera, Inc. [Member] Scithera, Inc. Total operating expenses Operating Expenses Money market funds Money Market Funds [Member] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Diluted (in dollars per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount License fee revenue License, Non-Affiliate [Member] License, Non-Affiliate Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Research and development Total research and development expense Research and Development Expense 2029 Long-Term Debt, Maturity, Year Three Interest income Interest Income, Nonoperating Interest Income, Nonoperating Share-Based Payment Arrangement [Abstract] Other outside research and development Accrued Outside Research And Development, Other, Current Accrued Outside Research And Development, Other, Current Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Property and equipment, net Property and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Liquidity threshold Long Term Debt, Liquidity Threshold Long Term Debt, Liquidity Threshold Vested and exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Issuance of shares upon exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Vested and exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Weighted-average discount rate (as a percent) Operating Lease, Weighted Average Discount Rate, Percent Number of shares authorized, currently available (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Segment Reporting [Table] Segment Reporting [Table] Schedule of Maturities of Long-Term Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Sale of Stock [Axis] Sale of Stock [Axis] Other Other Assets, Current Adjustments to reconcile net loss to net cash used in operating activities: Cash Provided by (Used in) Operating Activity, Continuing Operation [Abstract] Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Clinical drug substance and product manufacturing Accrued Clinical Drug Substance and Product Manufacturing, Current Accrued Clinical Drug Substance and Product Manufacturing, Current Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Loss from operations Operating Income (Loss) Current Fiscal Year End Date Current Fiscal Year End Date Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Common stock, shares issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Amortization of debt discount Amortization of Debt Discount (Premium) Equity Components [Axis] Equity Components [Axis] Accounts receivable Increase (Decrease) in Accounts Receivable Product and Service [Domain] Product and Service [Domain] Cash paid for income taxes Income Tax Paid, after Refund Received Entity Interactive Data Current Entity Interactive Data Current LICENSE REVENUES License And Grant Revenue [Text Block] License And Grant Revenue Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Small Business Entity Small Business Less: debt discount Less: unamortized debt discount Debt Instrument, Unamortized Discount Termination Date Trading Arrangement Termination Date Property, Plant, and Equipment [Line Items] Property, Plant, and Equipment [Line Items] Subsequent Events [Abstract] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Contractual term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Other non-current assets Other Assets, Noncurrent Reportable Segment Reportable Segment [Member] Reportable Segment Document Type Document Type Outside research and development services Outside Research And Development Services, Prepaid Expense Current Outside Research And Development Services, Prepaid Expense Current Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Accrued expenses Accrued expenses Accrued Liabilities, Current Fair Value as of Grant Date Award Grant Date Fair Value Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Arrangement Duration Trading Arrangement Duration Subsequent Event [Line Items] Subsequent Event [Line Items] Statement of Stockholders' Equity [Abstract] Proceeds from issuance of long-term debt Proceeds from Issuance of Long-Term Debt Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Loss before income tax expense Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Warrants exercise period Warrants and Rights Outstanding, Term Commitments and contingencies (Note 7) Commitments and Contingencies Total revenue Revenue Total license revenue Revenues Total property and equipment Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Machinery and equipment Machinery and Equipment [Member] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Vesting period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Furniture, fixtures, and other Furniture and Fixtures [Member] Liabilities and stockholders’ equity (deficit) Liabilities and Equity [Abstract] Award Type [Domain] Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount 2026 (6 months) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Level 3 Fair Value, Inputs, Level 3 [Member] Supplemental disclosure of cash flow information Supplemental Cash Flow Information [Abstract] Prepayment fee percentage Debt Instrument, Prepayment Fee Debt Instrument, Prepayment Fee Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Weighted Average Remaining Contractual Term, vested and exercisable (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted-Average Remaining Contractual Term PEO Name PEO Name Accrued expenses Increase (Decrease) in Accrued Liabilities Leasehold improvements Leasehold Improvements [Member] Long-Lived Asset, Class [Axis] Long-Lived Asset, Class [Axis] Concentrations of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Interest expense Accrued Interest Expense, Current Accrued Interest Expense, Current Receivables from related parties Increase (Decrease) in Due from Related Parties Entity Tax Identification Number Entity Tax Identification Number Debt interest expense Interest Expense, Debt Class of warrant or right, purchase price of warrants or rights (in shares) Class of Warrant or Right, Purchase Price of Warrants or Rights1 Class of Warrant or Right, Purchase Price of Warrants or Rights1 Personnel General And Administrative Expense, Personnel General And Administrative Expense, Personnel Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Professional fees Accrued Professional Fees, Current Collaborative Arrangements And Noncollaborative Arrangement Transactions Line Items Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Accounts payable Increase (Decrease) in Accounts Payable Other Other Accrued Liabilities, Current Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Percentage of principal amount for final payment Debt Instrument, Periodic Payment Terms, Balloon Payment To Be Paid, Percent Debt Instrument, Periodic Payment Terms, Balloon Payment To Be Paid, Percent Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Debt Instrument [Axis] Debt Instrument [Axis] Subsequent Event [Table] Subsequent Event [Table] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Customer [Domain] Customer [Domain] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Basic (in dollars per share) Earnings Per Share, Basic Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Long-term debt, net Long-Term Debt, Excluding Current Maturities Award Type [Axis] Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Oxford Warrants 2025 Oxford Warrants 2025 [Member] Oxford Warrants 2025 Issuance of warrants in connection with March 2026 Amendment to the 2025 Loan Agreement Fair value of warrants Adjustments to Additional Paid in Capital, Warrant Issued Accumulated deficit Retained Earnings (Accumulated Deficit) Product and Service [Axis] Product and Service [Axis] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Proceeds from the issuance of debt Proceeds from Issuance of Secured Debt Common Stock Common Stock [Member] Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Schedule of License and Grant Revenue Schedule Of License And Grant Revenue [Table Text Block] Schedule Of License And Grant Revenue Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Cover [Abstract] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Oxford Warrants 2026 Oxford Warrants 2026 [Member] Oxford Warrants 2026 Equity Awards Adjustments Equity Awards Adjustments [Member] Total liabilities and stockholders’ equity (deficit) Liabilities and Equity Outstanding stock options Options to purchase common stock issued and outstanding Stock Options Share-Based Payment Arrangement, Option [Member] Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Plan Name [Axis] Plan Name [Axis] Line of credit facility maximum borrowing capacity accordion feature Line Of Credit Facility Maximum Borrowing Capacity Accordion Feature Line Of Credit Facility Maximum Borrowing Capacity Accordion Feature Tabular List, Table Tabular List [Table Text Block] Vesting [Axis] Vesting [Axis] Additional paid-in-capital Additional Paid in Capital Personnel Research And Development Expense, Personnel Research And Development Expense, Personnel Other expense, net Other Nonoperating Income (Expense) Name Awards Close in Time to MNPI Disclosures, Individual Name Debt instrument, principal and interest term Debt Instrument, Principal And Interest Term Debt Instrument, Principal And Interest Term Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value General and administrative Total general and administrative expense General and Administrative Expense Long-Lived Asset, Class [Domain] Long-Lived Asset, Class [Domain] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Table] Contract manufacturing Research And Development Expense, Contract Manufacturing Research And Development Expense, Contract Manufacturing Preferred stock, $0.0001 par value; 15,000,000 shares authorized as of June 30, 2026 and December 31, 2025; no shares issued or outstanding as of June 30, 2026 and December 31, 2025. Preferred Stock, Value, Issued Adjustment to Compensation: Adjustment to Compensation [Axis] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Statement of Cash Flows [Abstract] Credit Facility [Axis] Credit Facility [Axis] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Name Measure Name Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Debt Instrument [Line Items] Debt Instrument [Line Items] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Additional Paid-In Capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Name Trading Arrangement, Individual Name Cash and cash equivalents Cash and Cash Equivalent Schedule of Stock Options Activity Schedule of Stock Options Roll Forward [Table Text Block] Non-cash lease expense Operating Lease, Expense Company Selected Measure Amount Company Selected Measure Amount Payments included in measurement of lease liability Operating Lease, Payments Included in Measurement of Lease Liability Operating Lease, Payments Included in Measurement of Lease Liability Depreciation and amortization Total depreciation and amortization expense Depreciation, Depletion and Amortization Entity Address, Address Line Two Entity Address, Address Line Two Liquidity Liquidity [Policy Text Block] Liquidity Current assets: Assets, Current [Abstract] Non-PEO NEO Non-PEO NEO [Member] Entity Address, Address Line One Entity Address, Address Line One Provision for income taxes Provision for income taxes Income Tax Expense (Benefit) Award Timing Method Award Timing Method [Text Block] Net increase in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Other research and development Other Research and Development Expense Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Maximum potential milestone payments Maximum Potential Milestone Payments Maximum Potential Milestone Payments Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Statement [Table] Statement [Table] Restatement Determination Date: Restatement Determination Date [Axis] Proceeds from the exercise of stock options Proceeds from Stock Options Exercised Collaborative Arrangement and Arrangement Other than Collaborative [Abstract] Collaborative Arrangement and Arrangement Other than Collaborative Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Shares available for future equity grants Share-Based Payment Arrangement [Member] Revenue: Revenues [Abstract] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block]